A tunable brain-targeted PEGylated ginsenoside Rg1 derivative disrupts the ROS-mediated inflammasome-pyroptosis cascade to ameliorate Alzheimer's cognitive deficits
BJA Open
· Elsevier
Аннотация
Publication date: March 2027 Source: Biomaterials, Volume 338, Part B Author(s): Xing Zhu, Haoyu Liang, Lei Fan, Jinyao Bo, Fujie Diao, Yulu Qian, Guiyang Zhang, Weizu Li
Читать у издателя →
Цитирование
A tunable brain-targeted PEGylated ginsenoside Rg1 derivative disrupts the ROS-mediated inflammasome-pyroptosis cascade to ameliorate Alzheimer's cognitive deficits. // BJA Open. – URL: https://www.sciencedirect.com/science/article/pii/S0142961226007313?dgcid=rss_sd_all
A tunable brain-targeted PEGylated ginsenoside Rg1 derivative disrupts the ROS-mediated inflammasome-pyroptosis cascade to ameliorate Alzheimer's cognitive deficits. BJA Open. https://www.sciencedirect.com/science/article/pii/S0142961226007313?dgcid=rss_sd_all
“A tunable brain-targeted PEGylated ginsenoside Rg1 derivative disrupts the ROS-mediated inflammasome-pyroptosis cascade to ameliorate Alzheimer's cognitive deficits.” BJA Open.
@article{article4388,
title = {A tunable brain-targeted PEGylated ginsenoside Rg1 derivative disrupts the ROS-mediated inflammasome-pyroptosis cascade to ameliorate Alzheimer's cognitive deficits},
journal = {BJA Open},
url = {https://www.sciencedirect.com/science/article/pii/S0142961226007313?dgcid=rss_sd_all}
}